Anika K. Anam, MD
Assistant Professor of Medicine (Endocrinology)Cards
About
Research
Publications
2022
Insulin increases placental triglyceride as a potential mechanism for fetal adiposity in maternal obesity
Anam AK, Cooke KM, Dratver MB, O'Bryan JV, Perley LE, Guller SM, Hwang JJ, Taylor HS, Goedeke L, Kliman HJ, Vatner DF, Flannery CA. Insulin increases placental triglyceride as a potential mechanism for fetal adiposity in maternal obesity. Molecular Metabolism 2022, 64: 101574. PMID: 35970449, PMCID: PMC9440306, DOI: 10.1016/j.molmet.2022.101574.Peer-Reviewed Original ResearchConceptsDe novo lipogenesisFetal adiposityFatty acid uptakeMaternal obesityObese womenNormal weightExcess adiposityVillous explantsInsulin receptorNewborns of mothersNormal-weight womenAcid uptakePlacental villous explantsTranscription factor SREBP-1Insulin-like growth factor 2Effect of insulinFatty acid oxidationPlacental triglyceridesPlacental responsesElevated triglyceridesMaternal hyperglycemiaWeight womenGrowth factor 2Diabetes riskPlacental metabolismNewer Glucose-Lowering Medications and Potential Role in Metabolic Management of PCOS
Anam A, Inzucchi S. Newer Glucose-Lowering Medications and Potential Role in Metabolic Management of PCOS. 2022, 527-553. DOI: 10.1007/978-3-030-92589-5_26.ChaptersPolycystic ovary syndromeType 2 diabetes mellitusDiabetes mellitusSodium-glucose cotransporter 2 inhibitorsGLP-1 receptor agonistsDipeptidyl peptidase-4 inhibitorsWeight lossGLP-1 RAsCV risk factorsGlucose-lowering medicationsCotransporter 2 inhibitorsGlucose lowering medicationsPeptidase-4 inhibitorsHigh-risk populationCategories of medicationsAbnormal carbohydrate metabolismPart of standardCV outcomesLifestyle interventionOvary syndromeMetabolic sequelaeMetabolic abnormalitiesMetabolic managementSGLT2 inhibitorsPatient population
2021
Update on Osteoporosis Screening and Management
Anam AK, Insogna K. Update on Osteoporosis Screening and Management. Medical Clinics Of North America 2021, 105: 1117-1134. PMID: 34688418, DOI: 10.1016/j.mcna.2021.05.016.ChaptersConceptsLimited alcohol intakeNew anabolic therapiesLow bone massDual-energy X-ray absorptiometry measurementsBone mineral densityMetabolic bone diseasePostmenopausal womenAnabolic therapyFragility fracturesMicroarchitectural deteriorationSevere osteoporosisBone healthAlcohol intakeOsteoporosis screeningSmoking cessationVitamin DMineral densityPharmacologic agentsBone massBone diseaseHigh riskAbsorptiometry measurementsGold standardOsteoporosisBone tissue
2020
Comment on Rhee et al. Association Between Glycemic Status and the Risk of Parkinson Disease: A Nationwide Population-Based Study. Diabetes Care 2020;43:2169-2175.
Melgoza IP, Jilani R, Shehzad Z, Anam AK. Comment on Rhee et al. Association Between Glycemic Status and the Risk of Parkinson Disease: A Nationwide Population-Based Study. Diabetes Care 2020;43:2169-2175. Diabetes Care 2020, 44: e95-e96. PMID: 33972316, DOI: 10.2337/dc20-2406.Commentaries, Editorials and Letters
2016
Sa1605 Outcomes Related to Intravenous Fluid Selection for Patients Admitted With Hyponatremia and Decompensated Cirrhosis
Shen N, Anam A, Patel P, Schneider Y, Jesudian A. Sa1605 Outcomes Related to Intravenous Fluid Selection for Patients Admitted With Hyponatremia and Decompensated Cirrhosis. Gastroenterology 2016, 150: s340. DOI: 10.1016/s0016-5085(16)31195-7.Peer-Reviewed Original Research
2015
An Ostomy Bag Filled With Blood
Anam A, Saumoy M, Wan D. An Ostomy Bag Filled With Blood. The American Journal Of Gastroenterology 2015, 110: s444. DOI: 10.14309/00000434-201510001-01026.Peer-Reviewed Case Reports and Technical NotesGastric Bleeding in the Setting of Familial Mediterranean Fever
Anam A, Saumoy M, Wan D. Gastric Bleeding in the Setting of Familial Mediterranean Fever. The American Journal Of Gastroenterology 2015, 110: s523-s524. DOI: 10.14309/00000434-201510001-01189.Peer-Reviewed Case Reports and Technical NotesFluid Selection in Hospitalized Patients Admitted With Decompensated Cirrhosis and Hyponatremia
Shen N, Anam A, Jesudian A. Fluid Selection in Hospitalized Patients Admitted With Decompensated Cirrhosis and Hyponatremia. The American Journal Of Gastroenterology 2015, 110: s906. DOI: 10.14309/00000434-201510001-02177.Peer-Reviewed Original Research
Clinical Trials
Current Trials
Endometrium and Metabolism
HIC ID2000020045RoleSub InvestigatorPrimary Completion Date11/30/2026Recruiting Participants
Academic Achievements & Community Involvement
Clinical Care
Overview
Anika Anam, MD, is an endocrinologist who cares for patients with osteoporosis, metabolic bone disease, and type 1 and type 2 diabetes.
Dr. Anam has had a long-standing interest in endocrinology which was sparked by experiences caring for patients with diverse endocrine issues during medical school and her internal medicine residency.
“Endocrinology is fascinating because there is a wide range of complex pathophysiology and the opportunity to cultivate long-term relationships with patients while we work together to understand their condition,” Dr. Anam says. “There are several endocrine glands that communicate using hormones, and when these glands do not produce the proper amount of hormones, diseases can develop. My role is to diagnose and treat these conditions while considering the whole patient.”
She reassures patients that there are strategies for treating challenging diseases. For example, for patients with osteoporosis, “I let them know that a multipronged approach including lifestyle modifications, physical therapy, and pharmacotherapy can be successful. I help patients understand the various treatment options so that they can make choices that fit with their priorities and goals,” she says.
Dr. Anam also has clinical interests in obesity, polycystic ovary syndrome (PCOS), and transgender care. After completing her clinical endocrinology fellowship at Yale, she also completed a research fellowship at Yale during which she worked on research studies spanning metabolism and reproductive tract pathophysiology. An assistant professor at Yale School of Medicine, she is interested in medical education and clinical research studies in bone health.
Clinical Specialties
Fact Sheets
Type 2 Diabetes: Symptoms and Treatments
Learn More on Yale MedicineType 1 Diabetes: Symptoms, Causes, and Treatments
Learn More on Yale MedicineOsteoporosis
Learn More on Yale MedicineReproductive Options for Transgender Individuals
Learn More on Yale Medicine
Board Certifications
Endocrinology Diabetes & Metabolism
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2018
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2016
Yale Medicine News
News
News
- May 10, 2024
Building Capacity in Medical Students to Care for Transgender and Gender Diverse Patients
- June 15, 2023
Congratulations: MHS-Med Ed Pathway Graduates & Med Ed Fellows!
- February 12, 2023
ACES Announces New 2023 Cohort
- September 01, 2022Source: Yale Medicine
Prediabetes Is on the Rise—Here’s How To Reverse It
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
Events
- Yale Only
- Yale Only